This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : bfc8a928-7cbb-4884-9e17-f4370e56
Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone receptor
Low dose androgens do not facilitate receptor dimerization. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-52032-y A treatment paradox has recently come to light in prostate cancer: Blocking testosterone production halts tumor
Researchers have discovered the vital role of a hormone, that develops in men during puberty, in providing an early prediction of whether they could develop certain diseases in later life.
